Brain CT without contrast showed an old cortical infarct in the left parietal region. Magnetic resonance imaging on the 12th day showed a recent cortical infarct in the high right parietal region, and cortical atrophy localised in the left parietal region, without evidence of callosal lesions. A SPECT examination performed on the 10th day showed a left parietal perfusion deficit with hyperperfusion on the right parietal region. The patient was treated with ticlopidine from the first day; the abnormal motor behaviour as well as the foreign limb sensation gradually disappeared after the first week, but the loss of visual guidance of the affected limb and loss of sensation still persisted on discharge.
The phenomenon that one hand behaves independently of the patient's will was first described by Goldstein3 in 1908, while studying patients with callosal lesions. Since that initial report, several authors have described similar sensorimotor behaviour in association with lesions involving the corpus callosum, the mesial frontal lobes (cingulate gyrus and supplementary motor areas), combinations of both, or bifrontal lesions.4 Despite all these clinical descriptions, no unifying criteria were set for the "alien hand syndrome" or "alien hand sign" (depending on the authors). Aetiological theories all have in common some notion of disconnection (right from left, or sensory from motor) and some notion of released inhibition affecting activities of the alien hand.2 Feinberg et al5 suggested that alien hand syndrome was in fact two different entities, both from a clinical and anatomical perspective: a frontal alien hand syndrome and a callosal alien hand syndrome. The first type would result from damage in the supplementary motor areas, anterior cingulate gyrus and medial prefrontal cortex of the dominant hemisphere, and anterior corpus callosum, and would be clinically related to reflexive grasping and compulsive manipulation. The callosal type would be characterised primarily by intermanual conflict and requires only an anterior corpus callosum lesion.
More recently, alien limbs have also been described with other underlying pathology, such as corticobasal degeneration, and central sensory nuclei (thalamic), occipitoparietal, and internal capsule lesions.'6 In all the described cases, callosal, thalamic, or internal capsule lesions, added to cortical lesions were required. Doody et al' suggest that, alternatively, a large posterior infarct alone may be sufficient to give an alien hand syndrome, although this has never been reported. The clinical picture of these cases also fulfilled the criteria of the feeling of foreignness and autonomous movements seen in classic descriptions. Nevertheless, they also displayed other associated features such as cortical myoclonus, abnormal sensory functions, loss of visual guidance of the affected limb (optic ataxia), or movement disorders.
In our patient, the feeling of strangeness and imposed involuntary movements, together with the inability to recognise his hand without visual clues, gave the picture of alien hand syndrome. Toxic oil syndrome emerged in Spain in 1981, affecting 20 000 people after ingestion of rapeseed oil that was denatured with aniline for industrial use, subsequently refined in an attempt to detoxify it, and fraudulently directed to human consumption.' It caused an acute flu-like illness with interstitial pneumonitis that progressed in 15% of the patients to a chronic syndrome, characterised by scleroderma-like skin manifestations, sicca syndrome, arthritis, and various neurological disorders.2 These were acute encephalopathy, stroke-like episodes, and peripheral nerve lesions with acute or chronic axonal or, less often, demyelinating polyneuropathy. The neuropathy ranged from mild impairment to severe cases, wheel chair bound for months. Around 10% of these patients are still under medical surveillance, due to cardiorespiratory and neurological sequelae. The clinical features and proposed pathogenic mechanism of toxic oil syndrome are similar to the eosinophilia-myalgia syndrome. So far, the toxic substance has not been identified and the mechanisms of lesion of the peripheral nerves has not been established. An autoimmune mechanism has been proposed, but the role of autoimmunity is not clear. We have evaluated the presence of antiganglioside antibodies in patients with toxic oil syndrome and peripheral neuropathy.
Serum samples from 12 patients (two men and 10 women, age range 20-60; mean 43 9 (SD 16-7) years) with toxic oil syndrome and peripheral neuropathy were studied. Neuropathy was not progressive, except in one patient, in whom progression was established by repeated conduction studies. Two patients also had CNS disorders (myoclonia and hyperreflexia). Serum electrophoresis, erythrocyte sedimentation rate, complement study, latex fixation, and
